These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30635292)

  • 41. Authors' response to 'TAP deficiency is also a cause of bronchiectasis'.
    Whitters D; Stockley RA
    Thorax; 2013 May; 68(5):491. PubMed ID: 23717829
    [No Abstract]   [Full Text] [Related]  

  • 42. Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis.
    Mayer-Hamblett N; Kloster M; Rosenfeld M; Gibson RL; Retsch-Bogart GZ; Emerson J; Thompson V; Ramsey BW
    Clin Infect Dis; 2015 Sep; 61(5):707-15. PubMed ID: 25972024
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta-analysis.
    Yang JW; Fan LC; Lu HW; Miao XY; Mao B; Xu JF
    Clin Respir J; 2016 Nov; 10(6):731-739. PubMed ID: 25620629
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic colonization by Pseudomonas aeruginosa of patients with obstructive lung diseases: cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease.
    Valderrey AD; Pozuelo MJ; Jiménez PA; Maciá MD; Oliver A; Rotger R
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):20-7. PubMed ID: 20727465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pseudomonas eradication in cystic fibrosis: who will join the ELITE?
    Smyth AR
    Thorax; 2010 Apr; 65(4):281-2. PubMed ID: 20388748
    [No Abstract]   [Full Text] [Related]  

  • 46. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis.
    Davies G; Wells AU; Doffman S; Watanabe S; Wilson R
    Eur Respir J; 2006 Nov; 28(5):974-9. PubMed ID: 16899482
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of chronic Pseudomonas aeruginosa infection in the development of bronchiectasis.
    Nagaki M; Shimura S; Tanno Y; Ishibashi T; Sasaki H; Takishima T
    Chest; 1992 Nov; 102(5):1464-9. PubMed ID: 1424868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigational inhaled therapies for non-CF bronchiectasis.
    Antoniu SA
    Expert Opin Investig Drugs; 2018 Feb; 27(2):139-146. PubMed ID: 29338445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The existence of bronchiectasis predicts worse prognosis in patients with COPD.
    Mao B; Lu HW; Li MH; Fan LC; Yang JW; Miao XY; Xu JF
    Sci Rep; 2015 Jun; 5():10961. PubMed ID: 26077673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
    Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.
    Drobnic ME; Suñé P; Montoro JB; Ferrer A; Orriols R
    Ann Pharmacother; 2005 Jan; 39(1):39-44. PubMed ID: 15562142
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Multiple Faces of Non-Cystic Fibrosis Bronchiectasis. A Cluster Analysis Approach.
    Martínez-García MÁ; Vendrell M; Girón R; Máiz-Carro L; de la Rosa Carrillo D; de Gracia J; Olveira C
    Ann Am Thorac Soc; 2016 Sep; 13(9):1468-75. PubMed ID: 27348199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis.
    Gillham MI; Sundaram S; Laughton CR; Haworth CS; Bilton D; Foweraker JE
    J Antimicrob Chemother; 2009 Apr; 63(4):728-32. PubMed ID: 19193658
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    Wang H; Ji XB; Mao B; Li CW; Lu HW; Xu JF
    BMJ Open; 2018 Mar; 8(3):e014613. PubMed ID: 29540404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Colistin inhalation helps against Pseudomonas aeruginosa,].
    Reinhardt D
    MMW Fortschr Med; 2014 Nov; 156(20):40. PubMed ID: 25543364
    [No Abstract]   [Full Text] [Related]  

  • 56. Transmission of bacteria in bronchiectasis and chronic obstructive pulmonary disease: Low burden of cough aerosols.
    Stockwell RE; Chin M; Johnson GR; Wood ME; Sherrard LJ; Ballard E; O'Rourke P; Ramsay KA; Kidd TJ; Jabbour N; Thomson RM; Knibbs LD; Morawska L; Bell SC
    Respirology; 2019 Oct; 24(10):980-987. PubMed ID: 30919511
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of airway infection by Pseudomonas aeruginosa: a computed tomographic study.
    Miszkiel KA; Wells AU; Rubens MB; Cole PJ; Hansell DM
    Thorax; 1997 Mar; 52(3):260-4. PubMed ID: 9093343
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Editorial Commentary: Pseudomonas aeruginosa Eradication: How Do We Measure Success?
    Zemanick ET; Laguna TA
    Clin Infect Dis; 2015 Sep; 61(5):716-8. PubMed ID: 25972023
    [No Abstract]   [Full Text] [Related]  

  • 59. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.
    Haworth CS; Bilton D; Chalmers JD; Davis AM; Froehlich J; Gonda I; Thompson B; Wanner A; O'Donnell AE
    Lancet Respir Med; 2019 Mar; 7(3):213-226. PubMed ID: 30658914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lung transplantation for non-cystic fibrosis bronchiectasis.
    Rademacher J; Ringshausen FC; Suhling H; Fuge J; Marsch G; Warnecke G; Haverich A; Welte T; Gottlieb J
    Respir Med; 2016 Jun; 115():60-5. PubMed ID: 27215505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.